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Purpose: The association between stomach cancer and colorectal cancer is controversial. The purpose of this study was to 
determine the synchronous prevalence of colorectal neoplasms in patients with stomach cancer.
Methods: A total of 123 patients with stomach cancer (86 male) and 246 consecutive, age- and sex-matched persons with-
out stomach cancer were analyzed from July 2005 to June 2010. All of them underwent colonoscopy within 6 months after 
undergoing gastroscopy.
Results: The prevalence of colorectal neoplasms was significantly higher in the stomach cancer group (35.8%) than in the 
control group (17.9%) (P < 0.001). Colorectal neoplasms were more prevalent in the patients with stomach cancer (odds 
ratio [OR], 3.10; 95% confidence interval [CI], 1.71 to 5.63). In particular, the difference in the prevalence of colorectal neo-
plasms was more prominent in the patients above 50 years old (OR, 3.54; 95% CI, 1.80 to 6.98).
Conclusion: The results showed that the synchronous prevalence of colorectal neoplasms was higher in patients with stom-
ach cancer than in those without stomach cancer. Therefore, patients with stomach cancer should be regarded as a high-risk 
group for colorectal neoplasms, and colonoscopy should be recommended for screening.
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cers in stomach cancer patients surgically treated in South Korea 
found that colorectal cancer occurred most frequently [5]. How-
ever, there have been only a few studies on the synchronous prev-
alence of stomach cancer and colorectal cancer, so more studies 
on its causes, mechanisms and differences by region are needed.
According to statistics of the Korean Ministry of Health and Wel-
fare in 2007, stomach cancer was the most common in the coun-
try, and colorectal cancer ranked third and fourth in males and 
females, respectively [6]. Thus, the prevalence of stomach cancer 
and colorectal cancer is high in South Korea, and the country man-
ages the types of cancer through the national cancer screening pro-
gram. For colorectal cancer, the guideline for early detection of 
colorectal cancer enacted in 2001 recommends colonoscopy screen-
ing test from the age of 50 years for adults with no symptoms [7]. 
However, there is no criterion for colonoscopy in stomach cancer 
patients.
For the synchronous prevalence of stomach cancer and colorec-
tal cancer, while the prevalence of stomach cancer is known to be 
lower or similar in patients with colorectal cancer in the West [8-
10], a higher prevalence of colorectal cancer in stomach cancer pa-
tients has been continuously reported in the East [11-13]. Thus, 
studies on the prevalence of stomach cancer and colorectal cancer 
INTRODUCTION
With the increasing aging population, the development of diagnos-
tic techniques for cancer and the increase of environmental expo-
sure to carcinogens, the prevalence of multiple primary cancers 
has been increasing [1]. In East Asia, stomach cancer with a rela-
tively higher incidence rate compared to cancer in other organs 
shows a high rate of multiple primary cancers, and it has been re-
ported to be associated with colorectal cancer in many cases [2]. 
Studies in South Korea also have reported that the incidence of 
multiple primary cancers was the highest in stomach cancer [3, 4], 
and a current research on the incidence of multiple primary can-
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in the East and the West have shown conflicting results, which is 
closely related with genetic and environmental factors, but there 
have been nearly no studies on the synchronous prevalence of 
stomach cancer and colorectal cancer and its screening test. There-
fore, this study aims to investigate the association of colorectal neo-
plasms in stomach cancer patients compared to normal people by 
comparing the prevalence of colorectal neoplasms between per-
sons with and without stomach cancer and to determine the use-
fulness of colonoscopy as a screening test to detect colorectal neo-
plasms in stomach cancer patients.
METHODS
In this study, 123 patients, who were diagnosed as having stomach 
cancer through upper gastrointestinal endoscopy at Gyeongsang 
National University Hospital from July 2005 to June 2010 and who 
underwent colonoscopy within six months from the diagnosis, 
were included as the stomach cancer group. Among persons with-
out stomach cancer in the upper gastrointestinal endoscopy for the 
same period and taking colonoscopy within six months, 246 per-
sons matching the gender and the age distributions of the stom-
ach cancer group were selected as the control group. In the stom-
ach cancer and the control groups, persons with history of stom-
ach or colorectal surgery, history of colonoscopy within the last 
five years or colonoscopic polypectomy, family history of colorec-
tal cancer, infectious intestinal disease, or colon metastasis from 
stomach cancer and persons whose whole large intestine could not 
be observed in colonoscopy were excluded in this study.
With the subjects, their gender, age, diabetes, smoking, drinking, 
body mass index (BMI), administration of aspirin or non-steroid 
anti-inflammatory drugs (NSAIDs), findings of upper gastroin-
testinal endoscopy and pathological results, findings of colonos-
copy and pathological results, and stomach cancer stage were ret-
rospectively investigated with their medical record. Around 77.0 
to 93.8% of the data could be obtained from the medical records.
Because gender, age, diabetes, smoking, drinking, BMI and the 
administration of aspirin or NASIDs can affect the incidence of 
stomach cancer and colorectal cancer, their correlations with stom-
ach cancer and colorectal neoplasms were analyzed through a mul-
tiple regression analysis after revising them statistically in the stom-
ach cancer and the control groups. The staging of stomach cancer 
was based on the American Joint Committee on Cancer (AJCC) 
cancer staging manual, sixth edition [14], and only histological 
stomach adenocarcinomas were investigated in this study.
Colorectal adenomas were divided into villous, tubulovillous and 
villous adenomas based on the results of the pathological exami-
nation and were classified into less than 5 mm, 5-9 mm and over 
10 mm based on size. For the location of the colorectal neoplasm, 
the right colon, the left colon and the rectum were defined as from 
the caecum to the spleen flexure, from the descending colon to 
the sigmoid colon, and lower than the rectosigmoid junction, re-
spectively. The number of colorectal neoplasms was divided into 
0-3, 4-6, and 7 or more than 7.
All statistical analyses were conducted with SPSS ver. 18.0 (SPSS 
Inc., Chicago, IL, USA). The statistical significances of continuous 
and categorical variables were analyzed with the independent t-test 
and the chi-square test, respectively. To calculate the odds ratio of 
advanced colorectal neoplasms, a multiple regression analysis was 
utilized by revising drinking, smoking, BMI, diabetes and the ad-
ministration of aspirin or NSAIDs with a 95% confidence interval. 
Statistical significance was determined as a P value of less than 0.05.
RESULTS
Clinical characteristics of the stomach cancer and the 
control groups
The mean age of the subjects was 62.1 ± 12.7 years, and males ac-
counted for 69.9%. Because the subjects in the control group were 
selected by matching their gender and age to those of the stomach 
cancer group, there were no differences in gender and age between 
the two groups. The rate of smokers was significantly higher in the 
stomach cancer group than in the control group, being 43.1% (50/ 
123) and 24.3% (53/246), respectively (P < 0.001). BMI, drinking, 
diabetes and the administration of aspirin or NSAIDs did not show 
any significant differences between the two groups (Table 1).
Prevalence and characteristics of colorectal neoplasms
The prevalences of colorectal neoplasms were 35.8% (44/123) and 
17.9% (44/246) in the stomach cancer and the control groups, re-
Table 1. Basal characteristics of the patients and the control group
Stomach  
cancer patients   
(n = 123)
Controls  
(n = 246)
P-value
Age (yr) 62.1 ± 12.7 62.07 ± 12.7 1.0
Male (%) 69.9 69.9 1.0
BMI (n = 284, 77%) 22.9 ± 2.6 23.1 ± 3.6 0.65
Smoking (n = 334, 90.5%)  <0.001
   No or former  66 (56.9) 165 (75.7)
   Current 50 (43.1)   53 (24.3)
Diabetes (n = 346, 93.8%)  0.66
   No 101 (87.8) 199 (86.1)
   Yes    14 (12.2) 32 (13.9)
Alcohol (n = 334, 90.5%)  0.73
   No    65 (56.0) 118 (54.1)
   Yes   51 (44.0) 100 (45.9)
Aspirin or NSAIDs (n = 321, 87.0%)  0.92
   No    93 (83.8) 175 (83.3)
   Yes    18 (16.2)   35 (16.7)
Values are presented as mean ± SD or number (%).
BMI, body mass index; NSAIDs, non steroid anti-inflammatory drugs.Journal of The Korean Society of
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spectively, and the prevalence in the stomach cancer group was 
significantly higher (Table 2). When a multiple regression analysis 
was performed by revising BMI, diabetes, smoking, drinking and 
the administration of aspirin or NSAIDs in the two groups, the 
prevalence of colorectal neoplasms was higher in the stomach 
cancer group than in the control group (odds ratio [OR], 3.10; 95% 
confidence interval [CI], 1.71 to 5.63). In particular, the odds ratio 
of the stomach cancer group to the control group was 3.54 in sub-
jects aged over 50 years, so their prevalence of colorectal neoplasms 
was higher compared to that in subjects aged less than 50 years.
Comparison of the location of the colorectal neoplasm between 
the two groups found that the rate in the right colon (45.5%) was 
higher than that in the left colon (36.4%) in the stomach cancer 
group while the rates in both the right colon and the left colon 
were the same, 43.2%, in the control group.
For the size of a colorectal neoplasm, neoplasms with sizes of less 
than 5 mm, 5-9 mm, and 10 or more than 10 mm accounted for 
47.7%, 27.3%, and 25.0%, respectively, in the stomach cancer group 
and 52.3%, 27.3%, and 20.5%, respectively, in the control group, but 
this difference was not statistically significant. The distribution of 
the number of colorectal neoplasms also was not significantly dif-
ferent as the rates of 0-3, 4-6, and 7 or more than 7 were 84.1%, 
13.6%, and 52.3%, respectively, in the stomach cancer group and 
90.9%, 6.8%, and 2.3%, respectively, in the control group. The path-
ological results for the colorectal neoplasms were villous, tubulo-
villous and villous adenoma and colorectal cancer in 79.5%, 2.3%, 
11.4%, and 6.8% of the stomach cancer group, respectively, and in 
86.4%, 6.8%, 6.8%, and 0.0% of the control group, but the differ-
ence between the two groups was not statistically significant.
Prevalence of colorectal neoplasms by stomach cancer stage
The stage of stomach cancer was found to be stage 1, 2, 3, and 4 in 
59 (51.8%), 21 (18.4%), 12 (10.5%), and 22 (19.3%) patients, respec-
tively, and the prevalence of colorectal neoplasms in stage 1, 2, 3, 
and 4 showed no significant difference, being 35.6% (21/59), 23.8% 
(5/21), 25% (3/12), and 50% (11/22), respectively (Table 3).
DISCUSSION
The reported correlations between stomach cancer and colorectal 
cancer are inconsistent [15]. According to many studies in the West, 
the prevalence of stomach cancer was lower or similar in colorec-
tal cancer patients than in the general population [8-10]. However, 
current research in Asian has reported that the prevalence of colo-
rectal cancer is higher in stomach- cancer patients and studies con-
ducted in South Korea have also found that the prevalence of colo- 
rectal cancer is higher in patients with stomach cancer [11, 12]. 
Therefore, the epidemiological correlation of the synchronous prev-
alence of colorectal cancer in stomach- cancer patients has not been 
determined clearly, and more studies are clearly necessary.
One hypothesis to explain the correlation between stomach can-
cer and colorectal cancer is their genetic correlation. APC, p53 and 
K-ras are already known to show the same genetic changes in stom-
ach cancer and colorectal cancer [16-18]. Genes of hMSH2 and 
Table 2. Prevalence and characteristics of colorectal neoplasms
Stomach cancer 
patients
Controls P-value
Age group (yr)
   <50 6/25 (24.0) 8/50 (16.0) 1.77 (0.42-7.56)
a
   ≥50 38/98 (38.8) 36/196 (18.4) 3.54 (1.80-6.98)
a
   Total 44/123 (35.8) 44/246 (17.9) 3.10 (1.71-5.63)
a
Site distribution 0.75
   Right colon 20/44 (45.5) 19/44 (43.2)
   Left colon 16/44 (36.4) 19/44 (43.2)
   Rectum 8/44 (18.2) 6/44 (13.6)
Size (mm) 0.86
   <5 21/44 (47.7) 23/44 (52.3)
   5-9 12/44 (27.3) 12/44 (27.3)
   ≥10  11/44 (25.0) 9/44 (20.5)
Numbers 0.74
   0-3 37/44 (84.1) 40/44 (90.9)
   4-6 6/44 (13.6) 3/44 (6.8)
   ≥7 1/44 (2.3) 1/44 (2.3)
Histology 0.25
   Tubular 35/44 (79.5) 38/44 (86.4)
   Tubulovillous 1/44 (2.3) 3/44 (6.8)
   Villous 5/44 (11.4) 3/44 (6.8)
   Adenocarcinoma 3/44 (6.8) 0 (0.0)
The values were adjusted with age, body mass index, smoking, alcohol, diabetes, 
and use of aspirin or non-steroid anti-inflammatory drugs.
aValues are presented as odd ratio (95% confidence interval).
Table 3. Prevalence of colorectal neoplasms according to gastric cancer stage
Colorectal neoplasm
Gastric cancer stage
P-value
Stage I Stage II Stage III Stage IV
Yes  21 (35.6)   5 (23.8) 3 (25.0) 11 (50.0) 0.30
No   38 (64.4) 16 (76.2) 9 (75.0) 11 (50.0)
Total   59 21 12 22
Values are presented as number (%). Stage of gastric cancer was classified in accordance with AJCC cancer staging manual, 6th ed.Journal of The Korean Society of
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hMLH1 play a critical role in repairing the base pair mismatch 
found during DNA replication, and the changes of these genes, 
which are observed in 50% of hereditary nonpolyposis colorectal 
cancer patients, are important in the incidence of hereditary non-
polyposis colorectal cancer. In addition, as similar changes are 
shown in 10-15% of sporadic stomach cancer and colorectal can-
cer, the possibility of genetic mutation of hMSH2 and hMLH1 can 
be pointed to as a common genetic change in stomach cancer and 
colorectal cancer [19]. Microsatellite instability is caused by abnor-
mality of the DNA mismatch repair pathway, and it is observed in 
90% of hereditary nonpolyposis colorectal cancer patients, playing 
an important role in its incidence [20]. Moreover, microsatellite 
instability is shown in 18% of stomach cancer patients, 13-17% of 
colorectal cancer patients and 50% of multiple primary gastroin-
testinal cancer patients, so it is known to be closely related with the 
incidence of multiple primary gastrointestinal cancers [12, 19].
Another hypothesis is related with environmental factors, which 
means that factors of infectious disease, such as hyperglycemia, 
lipid foods, lack of fiber, obesity, smoking and JC virus (JCV) are 
at work in both stomach cancer and colorectal cancer patients [21-
27]. Smoking was reported to be significantly related with malig-
nant colorectal tumors with p53 expression and colorectal tumors 
with APC, K-ras and p53 transverse mutations [28]. In addition, 
p53 gene mutation was reported to be observed significantly more 
in smokers compared to non-smokers [29]. For obesity, the rela-
tive risks of colorectal cancer were high, being 1.5-2.0 and 1.2-1.5 
in males and females, respectively, and a similar relation was found 
in colorectal adenomas. Another study said that obesity was related 
with an adenocarcinoma of the gastric cardia [30]. Obesity pro-
vokes hyperinsulinemia, and insulin is known to work as a growth 
factor in the large intestine so that hyperglycemia plays a role as a 
risk factor of colorectal cancer through this mechanism [30]. This 
study analyzed these environmental factors by reflecting them in 
the clinical characteristics of the two groups. While BMI, diabetes, 
drinking and the administration of aspirin or NSAIDs were not 
significantly different between the two groups, the rate of smokers 
was significantly higher in the stomach cancer group than in the 
control group. However, when the prevalences of colorectal neo-
plasms in the two groups were analyzed by revising these variables 
through a logistic regression analysis, they were found not to in-
fluence the results of this study. As a finding that viral infectious 
disease caused by JCV or one of the polyoma viruses could lead to 
stomach cancer and colorectal cancer has been reported, the pos-
sibility for an infectious disease like one caused by JCV to contrib-
ute to both stomach cancer and colorectal cancer is also suggested 
[25-27].
A colorectal adenoma is a pre-stage lesion of cancer. A study of 
Chung et al. [31] in South Korea reported that the prevalence of 
colorectal adenomas increased at older ages, being 10%, 22%, and 
33% in the subjects in their 30s, 40s and 50s, respectively, and the 
overall incidence of colorectal adenomas is currently increasing. 
In this study, the prevalences of colorectal neoplasms were 35.8% 
and 17.9% in the stomach cancer and the control groups, respec-
tively, and the prevalence for all subjects was not much different 
from that in previous studies (23.8%, 88/369) (Table 2). When colo-
noscopy was conducted within six months in stomach cancer pa-
tients, the prevalence of colorectal neoplasms was significantly 
higher compared to persons without stomach cancer, and the risk 
of colorectal neoplasms was higher in subjects aged over 50 years 
with an odds ratio of 3.54 (95% CI, 1.80 to 6.98) than in those aged 
less than 50 years. This finding emphasizes the necessity of colo-
noscopy screening test in persons over 50 years of age. In addition, 
the prevalence of villous adenomas, which is more likely to prog-
ress to colorectal cancer compared to villous adenomas, was higher 
in the stomach cancer group than in the control group, and the 
prevalence of colorectal cancer also tended to be higher in the 
stomach cancer group. That supports the necessity of screening 
through colonoscopy in stomach cancer patients.
In comparison with previous studies on the synchronous preva-
lence of stomach neoplasms and colorectal neoplasms performed 
in Korea [11, 12, 32], the prevalences of overall colorectal adeno-
mas were similar, and the finding that the prevalence of colorectal 
adenomas was higher in the stomach neoplasm group was consis-
tent except for some regions. However, the subjects of this study 
were different from those of other studies as most of the subjects 
in this study were from rural areas mainly in Western Gyeongnam. 
Their mean age was comparatively old, 62.1 ± 12.7 years, the rate 
of smokers in the stomach cancer group (43.1%) was much higher, 
and the prevalence of diabetes was higher (stomach cancer group: 
12.2% vs. control group: 13.9%). Moreover, more fiber intake due 
to the diet, which following the rural geographical characteristics 
around Jiri mountain in western Gyeongnam, is also thought to 
have affected the incidence of colorectal neoplasms. However, ge-
netic factors have not been studied until now, and this study did 
not investigate them either, so future studies on them are necessary. 
Although this study included more elderly population and showed 
a higher prevalence of diabetes and a higher rate of smokers com-
pared to other studies, its results were not largely different from 
those of previous studies in South Korea because other factors, in-
cluding fiber intake, exposure to carcinogens and genetic predis-
positions, work together in a complex way. The analysis under the 
hypothesis that the prevalence of colorectal neoplasms would go 
up at a higher stomach cancer stage, did not find any significance, 
which needs to be confirmed through more studies.
As limitations of this study, it was a retrospective study using med-
ical records, and its subjects were limited to western Gyeongnam. 
Prospective studies in various regions with more cases are necessary.
Stomach cancer and colorectal cancer are common in South Ko-
rea, and screening tests for them have been performed as a part of 
the national cancer screening program. Although studies on the 
correlation between stomach cancer and colorectal cancer have 
been reported continuously and the awareness of the necessity of 
colonoscopy screening test in stomach cancer patients has in-
creased, clear guidelines on it have not been suggested. This study Journal of The Korean Society of
Coloproctology
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found that the prevalence of colorectal neoplasms was higher in 
stomach cancer patients than in the control group, and this find-
ing suggests that colonoscopy as a screening test for colorectal neo-
plasm is needed in patients diagnosed as having stomach cancer.
The results of studies on the synchronous prevalence of colorec-
tal neoplasms in stomach cancer patients are conflicting and their 
correlation is controversial. Therefore, we conducted this study to 
determine that correlation and found that the prevalence of colorec-
tal neoplasms was significantly higher in the stomach cancer group 
than in the control group. Thus, colonoscopy as a screening test 
for colorectal neoplasms is certainly considered to be necessary in 
stomach cancer patients.
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